MiDROPS® Platform Development

About EyeCRO

Founded in 2010 and based in Durham, North Carolina, EyeCRO has established itself as a global leader in preclinical ophthalmic research services, having served over 400 companies and institutions. Its core business is providing specialized CRO services, supported by a proprietary drug delivery technology, MiDROPS®, which is protected by broad international patents. The company leverages over two decades of collective scientific expertise and AAALAC-accredited facilities to generate reproducible data for clients advancing novel therapies for anterior and posterior segment eye diseases.

Therapeutic Areas